Cargando…

Are Estimates of the Health Opportunity Cost Being Used to Draw Conclusions in Published Cost-Effectiveness Analyses? A Scoping Review in Four Countries

BACKGROUND: When healthcare budgets are exogenous, cost-effectiveness thresholds (CETs) used to inform funding decisions should represent the health opportunity cost (HOC) of such funding decisions, but HOC-based CET estimates have not been available until recently. In recent years, empirical HOC-ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Vallejo-Torres, Laura, García-Lorenzo, Borja, Edney, Laura Catherine, Stadhouders, Niek, Edoka, Ijeoma, Castilla-Rodríguez, Iván, García-Pérez, Lidia, Linertová, Renata, Valcárcel-Nazco, Cristina, Karnon, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021093/
https://www.ncbi.nlm.nih.gov/pubmed/34964092
http://dx.doi.org/10.1007/s40258-021-00707-8
_version_ 1784689727152062464
author Vallejo-Torres, Laura
García-Lorenzo, Borja
Edney, Laura Catherine
Stadhouders, Niek
Edoka, Ijeoma
Castilla-Rodríguez, Iván
García-Pérez, Lidia
Linertová, Renata
Valcárcel-Nazco, Cristina
Karnon, Jonathan
author_facet Vallejo-Torres, Laura
García-Lorenzo, Borja
Edney, Laura Catherine
Stadhouders, Niek
Edoka, Ijeoma
Castilla-Rodríguez, Iván
García-Pérez, Lidia
Linertová, Renata
Valcárcel-Nazco, Cristina
Karnon, Jonathan
author_sort Vallejo-Torres, Laura
collection PubMed
description BACKGROUND: When healthcare budgets are exogenous, cost-effectiveness thresholds (CETs) used to inform funding decisions should represent the health opportunity cost (HOC) of such funding decisions, but HOC-based CET estimates have not been available until recently. In recent years, empirical HOC-based CETs for multiple countries have been published, but the use of these CETs in the cost-effectiveness analysis (CEA) literature has not been investigated. Analysis of the use of HOC-based CETs by researchers undertaking CEAs in countries with different decision-making contexts will provide valuable insights to further understand barriers and facilitators to the acceptance and use of HOC-based CETs. OBJECTIVES: We aimed to identify the CET values used to interpret the results of CEAs published in the scientific literature before and after the publication of jurisdiction-specific empirical HOC-based CETs in four countries. METHODS: We undertook a scoping review of CEAs published in Spain, Australia, the Netherlands and South Africa between 2016 (2014 in Spain) and 2020. CETs used before and after publication of HOC estimates were recorded. We conducted logit regressions exploring factors explaining the use of HOC values in identified studies and linear models exploring the association of the reported CET value with study characteristics and results. RESULTS: 1171 studies were included in this review (870 CEAs and 301 study protocols). HOC values were cited in 28% of CEAs in Spain and in 11% of studies conducted in Australia, but they were not referred to in CEAs undertaken in the Netherlands and South Africa. Regression analyses on Spanish and Australian studies indicate that more recent studies, studies without a conflict of interest and studies estimating an incremental cost-effectiveness ratio (ICER) below the HOC value were more likely to use the HOC as a threshold reference. In addition, we found a small but significant impact indicating that for every dollar increase in the estimated ICER, the reported CET increased by US$0.015. Based on the findings of our review, we discuss the potential factors that might explain the lack of adoption of HOC-based CETs in the empirical CEA literature. CONCLUSIONS: The adoption of HOC-based CETs by identified published CEAs has been uneven across the four analysed countries, most likely due to underlying differences in their decision-making processes. Our results also reinforce a previous finding indicating that CETs might be endogenously selected to fit authors’ conclusions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40258-021-00707-8.
format Online
Article
Text
id pubmed-9021093
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-90210932022-05-04 Are Estimates of the Health Opportunity Cost Being Used to Draw Conclusions in Published Cost-Effectiveness Analyses? A Scoping Review in Four Countries Vallejo-Torres, Laura García-Lorenzo, Borja Edney, Laura Catherine Stadhouders, Niek Edoka, Ijeoma Castilla-Rodríguez, Iván García-Pérez, Lidia Linertová, Renata Valcárcel-Nazco, Cristina Karnon, Jonathan Appl Health Econ Health Policy Systematic Review BACKGROUND: When healthcare budgets are exogenous, cost-effectiveness thresholds (CETs) used to inform funding decisions should represent the health opportunity cost (HOC) of such funding decisions, but HOC-based CET estimates have not been available until recently. In recent years, empirical HOC-based CETs for multiple countries have been published, but the use of these CETs in the cost-effectiveness analysis (CEA) literature has not been investigated. Analysis of the use of HOC-based CETs by researchers undertaking CEAs in countries with different decision-making contexts will provide valuable insights to further understand barriers and facilitators to the acceptance and use of HOC-based CETs. OBJECTIVES: We aimed to identify the CET values used to interpret the results of CEAs published in the scientific literature before and after the publication of jurisdiction-specific empirical HOC-based CETs in four countries. METHODS: We undertook a scoping review of CEAs published in Spain, Australia, the Netherlands and South Africa between 2016 (2014 in Spain) and 2020. CETs used before and after publication of HOC estimates were recorded. We conducted logit regressions exploring factors explaining the use of HOC values in identified studies and linear models exploring the association of the reported CET value with study characteristics and results. RESULTS: 1171 studies were included in this review (870 CEAs and 301 study protocols). HOC values were cited in 28% of CEAs in Spain and in 11% of studies conducted in Australia, but they were not referred to in CEAs undertaken in the Netherlands and South Africa. Regression analyses on Spanish and Australian studies indicate that more recent studies, studies without a conflict of interest and studies estimating an incremental cost-effectiveness ratio (ICER) below the HOC value were more likely to use the HOC as a threshold reference. In addition, we found a small but significant impact indicating that for every dollar increase in the estimated ICER, the reported CET increased by US$0.015. Based on the findings of our review, we discuss the potential factors that might explain the lack of adoption of HOC-based CETs in the empirical CEA literature. CONCLUSIONS: The adoption of HOC-based CETs by identified published CEAs has been uneven across the four analysed countries, most likely due to underlying differences in their decision-making processes. Our results also reinforce a previous finding indicating that CETs might be endogenously selected to fit authors’ conclusions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40258-021-00707-8. Springer International Publishing 2021-12-29 2022 /pmc/articles/PMC9021093/ /pubmed/34964092 http://dx.doi.org/10.1007/s40258-021-00707-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Systematic Review
Vallejo-Torres, Laura
García-Lorenzo, Borja
Edney, Laura Catherine
Stadhouders, Niek
Edoka, Ijeoma
Castilla-Rodríguez, Iván
García-Pérez, Lidia
Linertová, Renata
Valcárcel-Nazco, Cristina
Karnon, Jonathan
Are Estimates of the Health Opportunity Cost Being Used to Draw Conclusions in Published Cost-Effectiveness Analyses? A Scoping Review in Four Countries
title Are Estimates of the Health Opportunity Cost Being Used to Draw Conclusions in Published Cost-Effectiveness Analyses? A Scoping Review in Four Countries
title_full Are Estimates of the Health Opportunity Cost Being Used to Draw Conclusions in Published Cost-Effectiveness Analyses? A Scoping Review in Four Countries
title_fullStr Are Estimates of the Health Opportunity Cost Being Used to Draw Conclusions in Published Cost-Effectiveness Analyses? A Scoping Review in Four Countries
title_full_unstemmed Are Estimates of the Health Opportunity Cost Being Used to Draw Conclusions in Published Cost-Effectiveness Analyses? A Scoping Review in Four Countries
title_short Are Estimates of the Health Opportunity Cost Being Used to Draw Conclusions in Published Cost-Effectiveness Analyses? A Scoping Review in Four Countries
title_sort are estimates of the health opportunity cost being used to draw conclusions in published cost-effectiveness analyses? a scoping review in four countries
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021093/
https://www.ncbi.nlm.nih.gov/pubmed/34964092
http://dx.doi.org/10.1007/s40258-021-00707-8
work_keys_str_mv AT vallejotorreslaura areestimatesofthehealthopportunitycostbeingusedtodrawconclusionsinpublishedcosteffectivenessanalysesascopingreviewinfourcountries
AT garcialorenzoborja areestimatesofthehealthopportunitycostbeingusedtodrawconclusionsinpublishedcosteffectivenessanalysesascopingreviewinfourcountries
AT edneylauracatherine areestimatesofthehealthopportunitycostbeingusedtodrawconclusionsinpublishedcosteffectivenessanalysesascopingreviewinfourcountries
AT stadhoudersniek areestimatesofthehealthopportunitycostbeingusedtodrawconclusionsinpublishedcosteffectivenessanalysesascopingreviewinfourcountries
AT edokaijeoma areestimatesofthehealthopportunitycostbeingusedtodrawconclusionsinpublishedcosteffectivenessanalysesascopingreviewinfourcountries
AT castillarodriguezivan areestimatesofthehealthopportunitycostbeingusedtodrawconclusionsinpublishedcosteffectivenessanalysesascopingreviewinfourcountries
AT garciaperezlidia areestimatesofthehealthopportunitycostbeingusedtodrawconclusionsinpublishedcosteffectivenessanalysesascopingreviewinfourcountries
AT linertovarenata areestimatesofthehealthopportunitycostbeingusedtodrawconclusionsinpublishedcosteffectivenessanalysesascopingreviewinfourcountries
AT valcarcelnazcocristina areestimatesofthehealthopportunitycostbeingusedtodrawconclusionsinpublishedcosteffectivenessanalysesascopingreviewinfourcountries
AT karnonjonathan areestimatesofthehealthopportunitycostbeingusedtodrawconclusionsinpublishedcosteffectivenessanalysesascopingreviewinfourcountries